Introduction
Live Live measles vaccines have been successfully administered to African children by the intradermal route using a spring-loaded needleless injector, the Dermojet (Cooper et al., 1966) . In an initial investigation in 1966, involving a small number of children in the United Kingdom (Sutcliffe et al., 1967) five vaccines of different titres were prepared from the Schwarz strain of further-attenuated measles virus and injected intradermally in children aged between 9 months and 2 years. The results suggested that successful antibody response could be expected in substantially all children following intradermal vaccination, using the accepted standard immunizing dose of virus, approximately 1000 Tissue Culture Doses (TCDi) contained in 01 ml. These preliminary studies also suggested that post-vaccination reactions might be reduced using the intradermal route. In a period of 16 months following successful vaccination children exposed to measles have remained fully protected (Sutcliffe, Burland & Hitchens, 1968) .
Materials and methods
The investigation was extended and live furtherattenuated vaccines of the Schwarz strain were prepared containing 1000 TCD50 in 01 ml for intradermal injection and 1000 TCD5 in 0-5 ml for subcutaneous injection by syringe and needle. They were prepared from a single batch of antigen.
(1) Measles antibody titre was estimated in each of eighty-eight children aged between 4 and 18 years in a hospital for the mentally subnormal. Twenty-five were subsequently vaccinated with one or other of the vaccines. The choice was made at random and children received intradermal vaccination using an Intrajet, an apparatus similar in design to the Dermojet but delivering 0-1 ml consistently. All the children were closely observed during the 2 weeks following vaccination, daily records of symptoms arising in vaccinated and unvaccinated children were kept by the nursing staff. Six weeks after vaccination a second sample of blood was taken from vaccinated children for re-estimation of measles antibody. Antibody titrations were carried out by haemagglutination inhibition (HI) as described by Norrby (1962).
(2) Two groups of normal, healthy children aged between, approximately, 12 and 24 months and attending an infant welfare clinic received the same vaccine using one or other of the two methods of administration. It was not possible to obtain sufficient blood from these children to measure antibody levels but each child was visited at home twice during the 2nd week following vaccination so that details of any illness in the 2 weeks after vaccination coud be reported. One hundred and ninety children were followed, ninety-six of these received 05 ml by subcutaneous injection and ninety-four 0-1 ml by the intradermal route.
Results
(1) The results of the investigation in the hospital population have been described elsewhere (Simpson & Burland, 1969) . Thirteen children were vaccinated intradermally and twelve subcutaneously, eight of these children had an antibody level of 1: 8 and one a level of 1: 12 before vaccination, the remaining sixteen had titres below 1: 8 ( in the two groups. One child developed a mild illness with a morbilliform rash and Koplik's spots after subcutaneous vaccination. Although eleven of the vaccinated children had epilepsy or a history of convulsions, none experienced seizures in the 2 weeks following vaccination.
(2) The symptoms recorded in the young infants are shown in Table 3 . There were more children with symptoms in the group vaccinated by syringe and needle but the difference is not significant. There were more children with each of the common symptoms such as coryza, cough and anorexia in that group.
Discussion
In the first investigation a dose of live furtherattenuated measles vaccine containing 1000 TCD50 Schwarz strain of virus produced an adequate rise in antibody level after intradermal injection. There was little difference in symptoms between the two vaccinated groups and between those and the unvaccinated group. The second investigation shows that although there appeared to be fewer young children with symptoms receiving vaccine by the intradermal route the difference was not significant. Of the forty-seven children in the hospital thought to have had measles an antibody titre of less than 1: 8 was found in nine (19 %), six of whom had reputedly suffered from measles within the previous 5 years. Krugman, Giles & Friedman (1966) found a mean HI antibody titre approaching 1 : 128 in their group of forty-six institutionalized children 6 years after natural measles infection. Only one child was found to have a titre below 1: 8. They also showed that children with low titres have a characteristic booster type of response after re-exposure to live measles virus. A second attack of measles is rare and failure to find antibody in young children after an illness supposed to have been measles implies misdiagnosis. Rubella, infectious mononucleosis, roseola infantum and some infections with other viruses, as well as hypersensitivity to drugs such as phenobarbitone, epanutin and antibiotics may be mistaken for measles. It is likely, therefore, that some susceptible children will not be vaccinated. Experience with the hospital population described shows that vaccination of children already immune will simply result in a boost of antibody level without ill-effect and that where there is any reasonable doubt about the previous history of measles, vaccination is indicated.
